IDPC and civil society partners highlight the deep-rooted racial inequalities in drug law enforcement, urging for reforms to dismantle systemic harm and discrimination.
This report summarises major topics from the meeting, such as the current geopolitical climate and the importance of rights-based policy for vulnerable communities.
UNAIDS, UNDP and INPUD synthesise models to support rights-based HIV responses, offer key principles, good practices, and expert insights from people who use drugs and specialists.
EHRA and partners analyse how shrinking civic space and punitive legal frameworks are undermining community-led HIV and TB responses in the region, directly impacting LGBTQI+ people, people who use drugs, sex workers, and people living with HIV.
EHRA provide a comparative assessment of harm reduction across Southeastern Europe, positioning political commitment and financing as critical to closing gaps.
Intersecção discusses how drug prohibition fuels deforestation, violence, and inequality across the region, linking the 'war on drugs' to the global climate crisis and calling for ecological harm reduction and rights-based regulation.
This collection examines Europe’s harm reduction journey, including early successes, uneven implementation, securitisation, stigma and medicalisation; and proposes a reframed, people-led approach centring wellbeing, acknowledging drug-use benefits, and advancing rights-based reforms.
The New Zealand Drug Foundation urges reform of outdated drug laws, calling for decriminalisation, Māori-led health approaches and investment in harm reduction to build safer, fairer, evidence-based policies for Aotearoa New Zealand.
The HIV Legal Network argues that laws criminalising simple possession and drug trafficking entrench racism and stigma, deepen inequality, and endanger health and safety by pushing drug use into isolation and heightening the risk of overdose.
C-EHRN highlights how European cities are responding to evolving drug trends through pragmatic, rights-based harm reduction, while fragmented governance and unstable funding continue to undermine capacity.
EHRA, alongside C-EHRN, EuroNPUD and DPNSEE, state that the exclusion, fragmentation, and underfunding of harm reduction and essential health services within Universal Health Coverage systems cause people who use drugs to experience disproportionately poor health outcomes across Europe.
